Hydroxytyrosol and dopamine metabolites: Anti-aggregative effect and neuroprotective activity against α-synuclein-induced toxicity.
暂无分享,去创建一个
[1] T. Richard,et al. Oxyresveratrol and Gnetol Glucuronide Metabolites: Chemical Production, Structural Identification, Metabolism by Human and Rat Liver Fractions, and In Vitro Anti-inflammatory Properties , 2022, Journal of agricultural and food chemistry.
[2] M. C. García-Parrilla,et al. Anti-VEGF Effect of Bioactive Indolic Compounds and Hydroxytyrosol Metabolites , 2022, Foods.
[3] C. Ríos,et al. Antioxidant Effect of Hydroxytyrosol, Hydroxytyrosol Acetate and Nitrohydroxytyrosol in a Rat MPP+ Model of Parkinson’s Disease , 2021, Neurochemical Research.
[4] C. Dobson,et al. The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril ends , 2020, Nature Communications.
[5] C. Follmer,et al. In Vitro Protective Action of Monomeric and Fibrillar α-Synuclein on Neuronal Cells Exposed to the Dopaminergic Toxins Salsolinol and DOPAL. , 2020, ACS chemical neuroscience.
[6] Amrendra P. Singh,et al. Design and in vitro analysis of SIRT2 inhibitor targeting Parkinson’s disease , 2020, Molecular Diversity.
[7] D. Agard,et al. Hsp70 chaperone blocks α-synuclein oligomer formation via a novel engagement mechanism , 2020, bioRxiv.
[8] M. Stefani,et al. Healthspan Maintenance and Prevention of Parkinson’s-like Phenotypes with Hydroxytyrosol and Oleuropein Aglycone in C. elegans , 2020, International journal of molecular sciences.
[9] D. Goldstein,et al. The catecholaldehyde hypothesis: where MAO fits in , 2019, Journal of Neural Transmission.
[10] A. M. Troncoso,et al. Melatonin, protocatechuic acid and hydroxytyrosol effects on vitagenes system against alpha-synuclein toxicity. , 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[11] M. Bucciantini,et al. Insight into the molecular mechanism underlying the inhibition of α-synuclein aggregation by hydroxytyrosol. , 2019, Biochemical pharmacology.
[12] D. Sulzer,et al. Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases. , 2019, Angewandte Chemie.
[13] D. Eliezer,et al. Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde. , 2018, ACS chemical neuroscience.
[14] D. Eliezer,et al. Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified α-synuclein. , 2018, Biochemical and biophysical research communications.
[15] P. Dušek,et al. Prevention of progression in Parkinson’s disease , 2018, BioMetals.
[16] M. Motilva,et al. Brain uptake of hydroxytyrosol and its main circulating metabolites: Protective potential in neuronal cells , 2018, Journal of Functional Foods.
[17] A. M. Troncoso,et al. Protective effects of hydroxytyrosol against α-synuclein toxicity on PC12 cells and fibril formation. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[18] M. Bucciantini,et al. Oleuropein aglycone stabilizes the monomeric α-synuclein and favours the growth of non-toxic aggregates , 2018, Scientific Reports.
[19] A. Mitchell,et al. Quantitation of Oleuropein and Related Phenolics in Cured Spanish-Style Green, California-Style Black Ripe, and Greek-Style Natural Fermentation Olives. , 2018, Journal of agricultural and food chemistry.
[20] A. M. Troncoso,et al. In Vitro Effects of Serotonin, Melatonin, and Other Related Indole Compounds on Amyloid‐&bgr; Kinetics and Neuroprotection , 2018, Molecular nutrition & food research.
[21] S. Lucchetti,et al. Phenolics fate in table olives (Olea europaea L. cv. Nocellara del Belice) debittered using the Spanish and Castelvetrano methods. , 2017, Food research international.
[22] M. Vendruscolo,et al. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation , 2017, Scientific Reports.
[23] P. Hanson,et al. SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson’s disease , 2017, BMC Neuroscience.
[24] Deborah Penque,et al. The mechanism of sirtuin 2–mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease , 2017, PLoS biology.
[25] L. Bubacco,et al. DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function , 2017, Scientific Reports.
[26] A. M. Troncoso,et al. Protocatechuic Acid: Inhibition of Fibril Formation, Destabilization of Preformed Fibrils of Amyloid-β and α-Synuclein, and Neuroprotection. , 2016, Journal of agricultural and food chemistry.
[27] A. Bax,et al. Toxic Dopamine Metabolite DOPAL Forms an Unexpected Dicatechol Pyrrole Adduct with Lysines of α-Synuclein. , 2016, Angewandte Chemie.
[28] A. Pastor,et al. Metabolic disposition and biological significance of simple phenols of dietary origin: hydroxytyrosol and tyrosol , 2016, Drug metabolism reviews.
[29] C. Piñol,et al. Differential absorption and metabolism of hydroxytyrosol and its precursors oleuropein and secoiridoids , 2016 .
[30] D. Eliezer,et al. Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)* , 2015, The Journal of Biological Chemistry.
[31] B. Tang,et al. SIRT1 in the brain—connections with aging-associated disorders and lifespan , 2015, Front. Cell. Neurosci..
[32] A. Singleton,et al. Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers , 2014, Brain : a journal of neurology.
[33] V. Calabrese,et al. Cellular stress response, redox status, and vitagenes in glaucoma: a systemic oxidant disorder linked to Alzheimer’s disease , 2014, Front. Pharmacol..
[34] D. Eliezer,et al. Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity , 2014, Front. Aging Neurosci..
[35] P. McLean,et al. Targeting heat shock proteins to modulate α-synuclein toxicity , 2014, Therapeutic advances in neurological disorders.
[36] Rick Morimoto. Creating a path from the heat shock response to therapeutics of protein-folding diseases: an interview with Rick Morimoto , 2014, Disease Models & Mechanisms.
[37] H. Kelebek,et al. Characterization of the Volatile, Phenolic and Antioxidant Properties of Monovarietal Olive Oil Obtained from cv. Halhali , 2013 .
[38] Daniel Weindl,et al. Complexity of dopamine metabolism , 2013, Cell Communication and Signaling.
[39] D. Teplow,et al. Effect of melatonin on α-synuclein self-assembly and cytotoxicity , 2012, Neurobiology of Aging.
[40] J. Segura-Aguilar,et al. Dopamine Oxidation and Autophagy , 2012, Parkinson's disease.
[41] P. McLean,et al. Protein degradation pathways in Parkinson’s disease: curse or blessing , 2012, Acta Neuropathologica.
[42] Nikolaos Scarmeas,et al. The association between Mediterranean diet adherence and Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[43] Beixue Gao,et al. Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2–mediated reversal of T-cell tolerance , 2012, Proceedings of the National Academy of Sciences.
[44] M. Palma,et al. Direct liquid chromatography method for the simultaneous quantification of hydroxytyrosol and tyrosol in red wines. , 2011, Journal of agricultural and food chemistry.
[45] M. Haigis,et al. Role of sirtuins and calorie restriction in neuroprotection: implications in Alzheimer's and Parkinson's diseases. , 2011, Current pharmaceutical design.
[46] P. Brundin,et al. A deadly spread: cellular mechanisms of α-synuclein transfer , 2011, Cell Death and Differentiation.
[47] Fred H. Gage,et al. In vivo demonstration that α-synuclein oligomers are toxic , 2011, Proceedings of the National Academy of Sciences.
[48] M. Mattson,et al. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. , 2010, Antioxidants & redox signaling.
[49] A. Braca,et al. Phenolic compounds in olive oil and olive pomace from Cilento (Campania, Italy) and their antioxidant activity , 2010 .
[50] D. Ehrnhoefer,et al. EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity , 2010, Proceedings of the National Academy of Sciences.
[51] P. Thonart,et al. Antioxidant phenolic compounds loss during the fermentation of Chétoui olives , 2009 .
[52] C. Pagliuca,et al. Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. , 2009, Molecular nutrition & food research.
[53] Yu-Tse Wu,et al. Measurement of free hydroxytyrosol in microdialysates from blood and brain of anesthetized rats by liquid chromatography with fluorescence detection. , 2009, Journal of chromatography. A.
[54] E. Calabrese,et al. Vitagenes, cellular stress response, and acetylcarnitine: Relevance to hormesis , 2009, BioFactors.
[55] R. Mayeux,et al. Mediterranean diet and mild cognitive impairment. , 2009, Archives of neurology.
[56] W. Burke,et al. Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine , 2008, Acta Neuropathologica.
[57] S. Sang,et al. Biotransformation of green tea polyphenols and the biological activities of those metabolites. , 2007, Molecular pharmaceutics.
[58] A. Macario,et al. Chaperonopathies by Defect, Excess, or Mistake , 2007, Annals of the New York Academy of Sciences.
[59] Brian C. Smith,et al. Linking SIRT2 to Parkinson's disease. , 2007, ACS chemical biology.
[60] Ruben Abagyan,et al. Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease , 2007, Science.
[61] Andre Fischer,et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis , 2007, The EMBO journal.
[62] L. Estevinho,et al. Table olives from Portugal: phenolic compounds, antioxidant potential, and antimicrobial activity. , 2006, Journal of agricultural and food chemistry.
[63] Abhinav K. Jain,et al. Phosphorylation of Tyrosine 568 Controls Nuclear Export of Nrf2* , 2006, Journal of Biological Chemistry.
[64] E. Boselli,et al. Phenolic composition and quality of white d.o.c. wines from Marche (Italy) , 2006 .
[65] J. Growdon,et al. Clinical and biochemical correlates of insoluble α-synuclein in dementia with Lewy bodies , 2006, Acta Neuropathologica.
[66] D. Butterfield,et al. Redox regulation in neurodegeneration and longevity: role of the heme oxygenase and HSP70 systems in brain stress tolerance. , 2004, Antioxidants & redox signaling.
[67] C. Mancuso. Heme oxygenase and its products in the nervous system. , 2004, Antioxidants & redox signaling.
[68] M. Komaitis,et al. High performance liquid chromatography analysis of phenolic substances in Greek wines , 2004 .
[69] D. Twelves,et al. Systematic review of incidence studies of Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.
[70] R. Foresti,et al. Regulation of heme oxygenase-1 by redox signals involving nitric oxide. , 2002, Antioxidants & redox signaling.
[71] Bruce A. Yankner,et al. Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease , 2002, Nature Medicine.
[72] M. Katan,et al. Olive oil phenols are absorbed in humans. , 2002, The Journal of nutrition.
[73] Michel Goedert,et al. Parkinsons Disease and other α-Synucleinopathies , 2001 .
[74] W. Burke,et al. Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. , 2001, Free radical biology & medicine.
[75] S. Gottesman,et al. Posttranslational quality control: folding, refolding, and degrading proteins. , 1999, Science.
[76] W. Burke,et al. Quantitation of 3,4-dihydroxyphenylacetaldehyde and 3, 4-dihydroxyphenylglycolaldehyde, the monoamine oxidase metabolites of dopamine and noradrenaline, in human tissues by microcolumn high-performance liquid chromatography. , 1999, Analytical biochemistry.
[77] R. Calabrese,et al. Identification and quantitation of hydroxytyrosol in Italian wines , 1998 .
[78] S. Fahn,et al. Neurodegeneration and neuroprotection in Parkinson disease , 2011, NeuroRX.
[79] E. Esposito,et al. Birth, life and death of dopaminergic neurons in the substantia nigra. , 2009, Journal of neural transmission. Supplementum.
[80] S. Salek,et al. A Review of the Health-Related Quality of Life and Economic Impact of Parkinson’s Disease , 2006, Drugs & aging.